» Articles » PMID: 18669897

Use of Ordinal Outcomes in Vascular Prevention Trials: Comparison with Binary Outcomes in Published Trials

Overview
Journal Stroke
Date 2008 Aug 2
PMID 18669897
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Vascular prevention trials mostly count "yes/no" (binary) outcome events, eg, stroke/no stroke. Analysis of ordered categorical vascular events (eg, fatal stroke/nonfatal stroke/no stroke) is clinically relevant and could be more powerful statistically. Although this is not a novel idea in the statistical community, ordinal outcomes have not been applied to stroke prevention trials in the past.

Methods: Summary data on stroke, myocardial infarction, combined vascular events, and bleeding were obtained by treatment group from published vascular prevention trials. Data were analyzed using 10 statistical approaches which allow comparison of 2 ordinal or binary treatment groups. The results for each statistical test for each trial were then compared using Friedman 2-way analysis of variance with multiple comparison procedures.

Results: Across 85 trials (335 305 subjects) the test results differed substantially so that approaches which used the ordinal nature of stroke events (fatal/nonfatal/no stroke) were more efficient than those which combined the data to form 2 groups (P<0.0001). The most efficient tests were bootstrapping the difference in mean rank, Mann-Whitney U test, and ordinal logistic regression; 4- and 5-level data were more efficient still. Similar findings were obtained for myocardial infarction, combined vascular outcomes, and bleeding. The findings were consistent across different types, designs and sizes of trial, and for the different types of intervention.

Conclusions: When analyzing vascular events from prevention trials, statistical tests which use ordered categorical data are more efficient and are more likely to yield reliable results than binary tests. This approach gives additional information on treatment effects by severity of event and will allow trials to be smaller.

Citing Articles

Statistical analyses of ordinal outcomes in randomised controlled trials: a scoping review.

Selman C, Lee K, Ferguson K, Whitehead C, Manley B, Mahar R Trials. 2024; 25(1):241.

PMID: 38582924 PMC: 10998402. DOI: 10.1186/s13063-024-08072-2.


Design of trials in lacunar stroke and cerebral small vessel disease: review and experience with the LACunar Intervention Trial 2 (LACI-2).

Blair G, Appleton J, Mhlanga I, Woodhouse L, Doubal F, Bath P Stroke Vasc Neurol. 2024; 9(6):581-594.

PMID: 38569894 PMC: 11791638. DOI: 10.1136/svn-2023-003022.


Optimising the analysis of vascular prevention trials: Re-Assessment of the TARDIS trial, the first prevention trial to adopt an ordinal primary outcome measure.

Woodhouse L, Montgomery A, Pocock S, James M, Ranta A, Bath P Contemp Clin Trials Commun. 2023; 35:101186.

PMID: 37745289 PMC: 10517366. DOI: 10.1016/j.conctc.2023.101186.


Bleeding with intensive versus guideline antiplatelet therapy in acute cerebral ischaemia.

Woodhouse L, Appleton J, Christensen H, Dineen R, England T, James M Sci Rep. 2023; 13(1):11717.

PMID: 37474599 PMC: 10359249. DOI: 10.1038/s41598-023-38474-2.


Statistical analyses of ordinal outcomes in randomised controlled trials: protocol for a scoping review.

Selman C, Lee K, Whitehead C, Manley B, Mahar R Trials. 2023; 24(1):286.

PMID: 37085929 PMC: 10119829. DOI: 10.1186/s13063-023-07262-8.